Zomedica Corp. Quarterly Income Tax Expense (Benefit) in USD from Q2 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Zomedica Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q2 2024.
- Zomedica Corp. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$143K, a 85.7% decline year-over-year.
- Zomedica Corp. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$232K, a 85.3% increase year-over-year.
- Zomedica Corp. annual Income Tax Expense (Benefit) for 2023 was $208K.
- Zomedica Corp. annual Income Tax Expense (Benefit) for 2022 was -$2.37M, a 1.41% decline from 2021.
- Zomedica Corp. annual Income Tax Expense (Benefit) for 2021 was -$2.33M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)